Dr. Reid Jilek and Mr. Donald Steinberg Appointed to Arris Holdings Inc.'s wholly owned U.S. Subsidiary Global Hemp Group, Inc.
December 18 2013 - 5:28PM
Marketwired
Dr. Reid Jilek and Mr. Donald Steinberg Appointed to Arris Holdings
Inc.'s wholly owned U.S. Subsidiary Global Hemp Group, Inc.
SURREY, BRITISH COLUMBIA--(Marketwired - Dec 18, 2013) - Arris
Holdings Inc. (CNSX:AAF)(FRANKFURT:ANI) ("Arris" or the "Company")
is pleased to announce the appointment of Dr. Reid Jilek and Donald
Steinberg to the board of directors of its U.S. subsidiary, Global
Hemp Group, Inc.
This newly formed Arris subsidiary will focus on opportunities
unfolding in the emerging hemp industry in the United States. Arris
management expects double-digit growth in this sector for the next
3 to 5 years. Arris and Global Hemp Group are positioning to
capitalize on this anticipated rapid growth and the business
opportunities that are developing.
"I look forward to working with the Global Hemp Group team,
helping guide the Company as it moves ahead with its ambitious
plans into this emerging industry," said Mr. Steinberg
In the 1980's Mr. Steinberg developed stock option programs that
led to management of floor traders on multiple option exchanges and
provided him with invaluable insight into the public markets and
public company management. Donald is a serial entrepreneur and has
launched multiple successful companies in his career. Notably, Mr.
Steinberg was the founder of the first publically traded medical
marijuana company on the U.S. stock market, Medical Marijuana,
Inc., which provides him with unique insight and industry
experience that will be invaluable in the execution of the Global
Hemp Group, Inc. business plan. Mr. Steinberg also has extensive
sales and marketing experience and has launched and managed several
successful direct sales platforms and will apply that knowledge and
expertise to the Global Hemp Group sales and marketing efforts as
well as oversee company wide operations.
Dr. Reid Jilek says, "I am very excited to be joining Global
Hemp Group and to utilize my network of international contacts to
tap the brain power and technologies that are required for the
evolution of this new and exciting sustainable industry".
Dr. Jilek has advanced degrees in the medical, life science and
engineering disciplines. He was both a Presidential Fellow and a
White House Fellow Candidate. He has published over 40 papers in
national and international peer--reviewed journals. After
completing his National Library of Medicine Post-Doctoral
developing computer and mathematical models for Malaria, he decided
to utilize his medical and scientific background in a business
development capacity by acting as a VP of Business Development for
private and public companies and a research institute. He was a
founding member of Frederick Research Center and of Asia Pacific
Alliance Company. He has served on the Board of Directors,
Scientific or Medical Advisory Boards, or Advisory Boards for more
than 40 private and public companies since 1990, in the US, Canada,
Mexico, Japan, Taiwan, China, Portugal, Moscow, Israel and Germany.
He has also served as the CEO of four companies and is now a member
of the Advisory Board for the Hemp Industrial Innovation Institute.
Dr. Jilek's extensive network of business, political, environmental
and social leaders in the world provides Global Hemp Group with a
unique source of knowledge and expertise that is invaluable to the
company.
On behalf of the board
Charles Larsen, CEO
Forward Looking Statements - Certain information set forth
in this news release may contain forward-looking statements that
involve substantial known and unknown risks and uncertainties.
These forward-looking statements are subject to numerous risks and
uncertainties, certain of which are beyond the control of the
Company, including, but not limited to the impact of general
economic conditions, industry conditions, volatility of commodity
prices, currency fluctuations, dependence upon regulatory
approvals, the availability of future financing and exploration
risk. Readers are cautioned that the assumptions used in the
preparation of such information, although considered reasonable at
the time of preparation, may prove to be imprecise and, as such,
undue reliance should not be placed on forward-looking statements.
The CNSX has not reviewed and does not accept responsibility for
the adequacy or accuracy of this release.
Arris Holdings Inc.Charles LarsenCEO1-604-592-6881 or
1-877-469-HEMP (4367)
Arn Linked Nrg Sel Sec Index (NYSE:ANI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Arn Linked Nrg Sel Sec Index (NYSE:ANI)
Historical Stock Chart
From Jul 2023 to Jul 2024